To the full analysis
Bayer stock: growth
BAYN.DEBayer reported $50.5B in revenue for fiscal 2025, down 2.2% on the prior year, up 1.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2.4%
per year from 2006 to 2025, per share 1.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
−0.6%
per year from 2006 to 2025, per share −1.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 1.9% | −0.1% | 2.4% |
| Revenue per share | 1.9% | −1.7% | 1.3% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −3.5% | −7.1% | −0.6% |
| Free cash flow per share | −3.5% | −8.6% | −1.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $32.09B | $1.68B | $2.58B |
| 2007 | $35.89B | $2.55B | $2.68B |
| 2008 | $36.48B | $1.9B | $2.05B |
| 2009 | $34.54B | $1.51B | $4.21B |
| 2010 | $38.88B | $1.44B | $4.72B |
| 2011 | $40.48B | $2.74B | $3.82B |
| 2012 | $44.04B | $2.66B | $2.88B |
| 2013 | $44.5B | $3.53B | $3.34B |
| 2014 | $45.81B | $3.8B | $3.81B |
| 2015 | $51.07B | $4.55B | $4.85B |
| 2016 | $38.72B | $5.02B | $7.21B |
| 2017 | $38.8B | $8.13B | $6.39B |
| 2018 | $40.71B | $1.88B | $5.9B |
| 2019 | $48.25B | $4.53B | $6.16B |
| 2020 | $45.88B | −$11.63B | $2.75B |
| 2021 | $48.85B | $1.11B | $2.75B |
| 2022 | $56.22B | $4.6B | $4.59B |
| 2023 | $52.79B | −$3.26B | $2.62B |
| 2024 | $51.64B | −$2.83B | $5.09B |
| 2025 | $50.5B | −$4.01B | $2.31B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.